Beta Bionics BBNX
NASDAQ BBNX
$18.87 -0.11 (-0.58%)
At close: Oct 1, 2026 · 4:00 PM EDT

Beta Bionics (BBNX) Return on Equity [ROE] (2025 - 2026)

Updated

Beta Bionics' Return on Equity [ROE] came in at -27.66% for Q2 2026, down 9.69 percentage points from -17.98% a year earlier and down 3.88 percentage points from the prior quarter.

Analysis

Beta Bionics (BBNX) Return on Equity [ROE] (2025 - 2026) Analysis & Trends

For FY2025, Beta Bionics' Return on Equity [ROE] was -287.57%.

  • The Q2 2026 figure represents the lowest quarterly Return on Equity [ROE] since Q1 2025.
  • Business Quant data shows BBNX's Return on Equity [ROE] at -23.78% (Q1 2026), -20.86% (Q4 2025) and -19.91% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn 13.36%
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn 10.39%
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn 7.56%
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn 17.60%
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn 10.44%
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn -3.90%
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn 14.31%
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn 9.53%
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn 3.88%
10 Beta Bionics 853.75 Mn 25.93 Mn 18.90 Mn -27.66%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -27.66%
Mar 31, 2026 -23.78%
Dec 31, 2025 -20.86%
Sep 30, 2025 -19.91%
Jun 30, 2025 -17.98%
Mar 31, 2025 -143.98%
API Access

Beta Bionics Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=BBNX&period=max&api_key=YOUR_API_KEY